TAX1BP1 Antibody

What is TAX1BP1 and why is it significant in immunological research?

TAX1BP1 (Tax1-binding protein 1) was initially identified as an interactant of the human T-lymphotropic virus 1 (HTLV-1) Tax oncoprotein through yeast two-hybrid screening . This approximately 90.9 kDa protein has emerged as a multifunctional regulator with significant roles in:

• Selective macroautophagy/autophagy as a receptor protein

• Host defense against pathogens, particularly in xenophagic clearance of bacteria like Salmonella typhimurium and Mycobacterium tuberculosis

• Regulation of innate immune signaling pathways, including NF-κB and JNK signaling

• Anti-apoptotic function by mediating TNFAIP3/A20 activity

• Viral interactions with multiple viral proteins including RSV-N, SARS-CoV-2 proteins, and papillomavirus E2

The protein contains several functional domains including an N-terminal SKICH domain, coiled-coil domains, and C-terminal zinc finger domains that facilitate its diverse protein-protein interactions .

What applications are TAX1BP1 antibodies most commonly validated for?

Based on the literature and manufacturer data, TAX1BP1 antibodies have been validated for multiple applications with varying success rates:

Researchers should select antibodies specifically validated for their intended application and verify reactivity with their species of interest (commonly human, mouse, or rat) .

How should I optimize Western blot detection of TAX1BP1?

For optimal Western blot detection of TAX1BP1:

• Sample preparation:

  • Use RIPA buffer with protease inhibitors

  • Include phosphatase inhibitors if studying phosphorylation states

  • Heat samples at 95°C for 5 minutes in reducing Laemmli buffer

• Gel selection:

  • Use 8-10% SDS-PAGE gels due to TAX1BP1's 90-91 kDa size

  • Transfer to PVDF membrane (preferred over nitrocellulose for this protein)

• Blocking and antibody incubation:

  • Block with 5% non-fat milk in TBST (5% BSA if studying phosphorylation)

  • Incubate with primary antibody (typically 1:1000-1:5000 dilution) overnight at 4°C

  • Use HRP-conjugated secondary antibodies at 1:5000-1:10000

• Expected results:

  • TAX1BP1 typically appears as a band at approximately 90 kDa

  • Verify specificity using TAX1BP1 knockout or knockdown controls

  • Some antibodies may detect additional bands representing isoforms or degradation products

• Special considerations:

  • TAX1BP1 levels may increase upon certain stimulations (e.g., viral infection)

  • When assessing protein stability, include proteasome inhibitors in experimental design

What are the critical controls when studying TAX1BP1 interactions with viral proteins?

When investigating TAX1BP1 interactions with viral proteins, the following controls are essential:

• Negative controls:

  • TAX1BP1 knockout/knockdown cells to confirm antibody specificity

  • Non-interacting viral protein controls to establish specificity

  • IgG isotype controls for immunoprecipitation experiments

• Positive controls:

  • Known TAX1BP1-interacting partners (e.g., TRAF6, A20)

  • Previously established viral protein interactions (e.g., HTLV-1 Tax, RSV N protein)

• Interaction validation approaches:

  • Reciprocal co-immunoprecipitation with both TAX1BP1 and viral protein antibodies

  • GST pull-down assays with recombinant proteins

  • Proximity ligation assays to confirm interactions in situ

  • Domain mapping using truncation mutants to identify interaction regions

• Functional validation:

  • Assess changes in viral replication in TAX1BP1-depleted cells

  • Evaluate effects on signaling pathways known to be regulated by TAX1BP1

  • Monitor localization changes of both TAX1BP1 and viral proteins during infection

Research has shown that TAX1BP1 interactions with viral proteins like papillomavirus E2 can stabilize these proteins by preventing proteasomal degradation, indicating the importance of studying functional consequences of these interactions .

How can I effectively investigate TAX1BP1's role in xenophagy and selective autophagy?

Investigating TAX1BP1's role in xenophagy and selective autophagy requires multi-faceted approaches:

• Bacterial infection models:

  • Infect cells with bacteria known to be targeted by xenophagy (Salmonella, Mycobacterium)

  • Compare bacterial clearance rates between wild-type and TAX1BP1-depleted cells

  • Assess co-localization of TAX1BP1, LC3, and bacteria using triple-label immunofluorescence

• Mechanistic studies:

  • Examine TAX1BP1 recruitment to bacterial entry sites using live-cell imaging

  • Assess interaction with ubiquitin and galectin-8 during bacterial invasion

  • Map the TAX1BP1 domains required for xenophagy using deletion mutants

  • Investigate the roles of TAX1BP1's LC3-interacting regions (LIRs) and ubiquitin-binding domains

• Autophagosome formation analysis:

  • Track LC3 puncta formation in the presence/absence of TAX1BP1

  • Examine autophagosome maturation using tandem-fluorescent LC3 constructs

  • Analyze autophagic flux using bafilomycin A1 treatment in TAX1BP1-depleted cells

• In vivo validation:

  • Use TAX1BP1 knockout mouse models to examine susceptibility to bacterial infection

  • Assess bacterial burden in different tissues

  • Evaluate inflammatory responses by cytokine profiling

Studies have revealed that the zinc finger 2 (ZF2) domain of TAX1BP1 is essential for its function in aggrephagy (clearance of protein aggregates), while different domains mediate its role in antibacterial xenophagy .

What approaches should I use to study TAX1BP1's role in regulating innate immune signaling?

To investigate TAX1BP1's regulatory functions in innate immune signaling:

• Cell stimulation experiments:

  • Treat cells with relevant stimuli (TNF-α, IL-1, LPS, poly(I:C), viral infection)

  • Compare signaling dynamics in wild-type versus TAX1BP1-depleted cells

  • Assess activation kinetics of NF-κB, JNK, and IRF3 pathways

• Biochemical analyses:

  • Monitor phosphorylation and dimerization of IRF3 following stimulation

  • Examine IκBα degradation and re-synthesis kinetics

  • Perform in vitro kinase assays for IKK and TBK1/IKKi activity

  • Assess polyubiquitination status of signaling components (TBK1, IKKi, RIG-I)

• Protein-protein interaction studies:

  • Investigate stimulus-dependent interactions between TAX1BP1 and A20

  • Identify key interaction partners in various signaling pathways

  • Map domains required for interactions with signaling components

• Functional readouts:

  • Measure cytokine/interferon production by ELISA or qPCR

  • Assess antiviral responses using virus replication assays

  • Evaluate cell survival following TNF-α stimulation

Research has demonstrated that TAX1BP1 knockout MEFs exhibit enhanced and persistent IKK kinase activity after IL-1 and TNF-α stimulation, indicating its critical role in terminating these inflammatory signaling pathways .

Why might I detect multiple bands when using a TAX1BP1 antibody, and how should I interpret them?

Multiple bands when using TAX1BP1 antibodies can result from various biological and technical factors:

• Biological explanations:

  • Protein isoforms: TAX1BP1 may have multiple isoforms resulting from alternative splicing

  • Post-translational modifications: Phosphorylation, ubiquitination, or other modifications can alter mobility

  • Proteolytic processing: TAX1BP1 is reported to be cleaved by caspase-3-like proteases during apoptosis

  • Fusion protein products: In gene trap experiments, fusion products like TAX1BP1(1-204)/βgeo have been reported

• Technical considerations:

  • Antibody specificity: Some bands may represent cross-reactivity with related proteins

  • Sample preparation: Insufficient denaturation or protein degradation during preparation

  • Transfer artifacts: Incomplete transfer or air bubbles can cause irregular bands

• Validation approaches:

  • Knockout/knockdown controls: Test the antibody in TAX1BP1-depleted samples to identify specific bands

  • Protein domain-specific antibodies: Compare N-terminal versus C-terminal antibodies

  • Immunoprecipitation followed by Western blot: To confirm identity of bands

  • Mass spectrometry: For definitive identification of proteins in different bands

Research shows that some TAX1BP1 knockout models may retain truncated versions of the protein (amino acids 1-204) , which could explain detection of unexpected lower molecular weight bands with N-terminal-specific antibodies.

How should I interpret changes in TAX1BP1 localization during infection or cellular stress?

Changes in TAX1BP1 localization can provide important insights into its functional roles:

• Interpretation framework:

  • Cytoplasmic to punctate structures: Often indicates recruitment to autophagosomes or protein aggregates

  • Co-localization with LC3: Suggests active involvement in autophagy processes

  • Association with bacterial inclusions: Indicates xenophagy activation

  • Nuclear translocation: May relate to transcriptional regulatory functions

  • Co-localization with viral proteins: Suggests direct interaction and potential functional modulation

• Methodological considerations:

  • Time-course analysis: Track localization changes at multiple time points after stimulus

  • Co-staining: Examine co-localization with organelle markers, autophagy proteins, and stimuli-specific factors

  • Live-cell imaging: For dynamic assessment of TAX1BP1 recruitment to structures

  • Super-resolution microscopy: To resolve fine details of protein complex formation

• Functional correlations:

  • Autophagy inhibitors: Test if treatment with wortmannin or bafilomycin A1 alters localization patterns

  • Domain mutants: Identify domains required for specific localization patterns

  • Correlation with phenotypes: Connect localization changes with functional outcomes like bacterial clearance

Studies have shown that TAX1BP1 is recruited to cytosolic Salmonella typhimurium in a manner dependent on ubiquitin and galectin-8, highlighting the importance of tracking these interactions during infection processes .

What methods are effective for studying TAX1BP1's role in aggrephagy and neurodegenerative disease models?

TAX1BP1 has recently been identified as an aggrephagy receptor crucial for clearing cytotoxic protein aggregates, particularly in the brain . To study this function:

• Cellular aggregate models:

  • Polyglutamine aggregates: Express polyQ-HTT (Huntington's disease model) in wild-type versus TAX1BP1-depleted cells

  • TDP-43 aggregates: Express aggregation-prone TARDBP/TDP-43 (ALS model)

  • Quantify aggregates: Use filter trap assays, fluorescence microscopy, or biochemical fractionation

  • Cell viability: Assess protection against aggregate-induced cytotoxicity

• Domain requirement analysis:

  • Generate ZF2 domain mutants of TAX1BP1, which are essential for aggrephagy function

  • Compare with LIR mutants to distinguish general autophagy from aggregate-specific functions

  • Perform rescue experiments in TAX1BP1-depleted cells

• Animal model approaches:

  • Cross TAX1BP1-deficient mice with neurodegenerative disease models

  • Analyze aggregate burden in brain tissues using immunohistochemistry

  • Assess behavioral phenotypes and disease progression

  • Evaluate potential therapeutic approaches targeting TAX1BP1 pathways

• Patient sample analyses:

  • Examine TAX1BP1 expression and localization in patient brain samples

  • Assess correlation between TAX1BP1 levels/function and disease severity

  • Investigate genetic variations in TAX1BP1 in patient cohorts

Recent studies have demonstrated that TAX1BP1's ZF2 domain is specifically required for clearing cytotoxic aggregates like polyQ-HTT and TARDBP/TDP-43, and its deficiency leads to increased aggregate formation and reduced cell viability .

How can I investigate the crosstalk between TAX1BP1's functions in autophagy and innate immune signaling?

Investigating the interconnection between TAX1BP1's dual roles requires integrated approaches:

• Stimulus-specific analyses:

  • Compare TAX1BP1 function during pathogen infection versus sterile inflammation

  • Assess temporal relationships between signaling modulation and autophagy induction

  • Determine if TAX1BP1-mediated autophagy targets signaling components for degradation

• Domain-specific approaches:

  • Generate mutants that selectively disrupt either autophagy or signaling functions

  • Identify domains required for each process and create separation-of-function mutants

  • Perform complementation studies with these mutants in TAX1BP1-deficient cells

• Signaling component degradation:

  • Track the autophagic degradation of innate immune signaling components like TICAM1 and MAVS

  • Assess how blockade of autophagy affects TAX1BP1's ability to terminate inflammatory signaling

  • Examine if TAX1BP1-mediated degradation of signaling components requires its interaction with A20

• In vivo validation:

  • Generate tissue-specific or inducible TAX1BP1 knockout models

  • Assess inflammation parameters and autophagy markers simultaneously

  • Evaluate disease models where both processes are implicated

Research has shown that TAX1BP1 regulates TLR3-TLR4 and DDX58/RIG-I-like receptor signaling by targeting TICAM1 and MAVS for autophagic degradation, demonstrating direct crosstalk between its autophagy and immune regulation functions .

What are the essential considerations when selecting a TAX1BP1 antibody for specific research applications?

When selecting a TAX1BP1 antibody, researchers should consider:

• Epitope location and specificity:

  • N-terminal-specific antibodies: Target the SKICH domain (amino acids 1-204)

  • C-terminal-specific antibodies: Target the coiled-coil or zinc finger domains

  • Peptide-specific antibodies: Target specific regions like amino acids 690-789 or 700-800

  • Different epitopes may reveal different aspects of TAX1BP1 biology or miss truncated forms

• Application-specific validation:

  Application	Key Selection Criteria	Recommended Validation
  Western Blot	Band size verification, knockout controls	Single band at ~90kDa
  IHC	Tissue-specific validation, antigen retrieval compatibility	Compare with mRNA expression data
  IF/ICC	Subcellular localization pattern, background	Co-localization with known partners
  IP	Efficient pull-down, minimal background	Mass spectrometry verification

• Host species considerations:

  • Select based on compatibility with other antibodies in multi-labeling experiments

  • Common hosts include rabbit (monoclonal and polyclonal) and mouse (monoclonal)

• Cross-reactivity:

  • Verify species reactivity (human, mouse, rat, etc.)

  • Some antibodies show cross-reactivity with cow and monkey samples

  • Cross-reactivity with TRAF6BP/TAX1BP1 should be considered

• Clone selection for monoclonal antibodies:

  • Specific clones like 2C3 and 3098C2a are available for certain applications

  • Different clones may have different properties and optimized applications

Researchers should review literature using specific antibodies and examine validation data from manufacturers before making selections .

How can I effectively use TAX1BP1 antibodies to study its interactions with viral and bacterial pathogens?

To effectively study TAX1BP1's interactions with pathogens:

• Infection models setup:

  • Viral infections: Use appropriate viral strains (RSV, HTLV-1, papillomavirus, SARS-CoV-2)

  • Bacterial infections: Establish models with Salmonella typhimurium or Mycobacterium tuberculosis

  • Time-course experiments: Capture early recruitment events through late clearance phases

• Visualization approaches:

  • Confocal microscopy: Co-stain for TAX1BP1, pathogen markers, and cellular proteins

  • Live-cell imaging: Track TAX1BP1 recruitment to pathogen entry sites in real-time

  • Electron microscopy: For ultrastructural localization of TAX1BP1 around pathogens

  • Proximity ligation assay: To detect direct interactions between TAX1BP1 and pathogen components

• Biochemical interaction studies:

  • Co-immunoprecipitation: Use TAX1BP1 antibodies to pull down viral/bacterial proteins

  • Pull-down assays: With recombinant viral proteins to map interaction domains

  • Cross-linking: To capture transient interactions during infection

  • Mass spectrometry: To identify TAX1BP1-interacting pathogen components comprehensively

• Functional assays:

  • Knockout/knockdown experiments: Compare pathogen clearance or replication

  • Reconstitution studies: Rescue with wild-type or mutant TAX1BP1

  • Cytokine profiling: Assess inflammatory responses during infection

  • Pathogen burden quantification: By CFU assays or viral titers

Studies have shown that TAX1BP1 interacts with viral proteins including HTLV-1 Tax, RSV N protein, SARS-CoV-2 proteins (M, NSP6, NSP9, ORF3A), and papillomavirus E2, revealing diverse roles in viral infection processes .